180 Degree Capital logo

180 Degree Capital

North America, New Jersey, United States, Montclair

Description

180 Degree Capital is a publicly traded registered closed-end management investment company.

Investor Profile

180 Degree Capital has made 92 investments, with 0 in the past 12 months and 3% as lead.

Stage Focus

  • Series B (27%)
  • Series Unknown (21%)
  • Series C (21%)
  • Series A (14%)
  • Series D (11%)
  • Series E (3%)
  • Debt Financing (2%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (95%)
  • Canada (3%)
  • United Kingdom (2%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Health Care
  • Electronics
  • Semiconductor
  • Nanotechnology
  • Life Science
  • Software
  • Hardware
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 180 Degree Capital frequently co-invest with?

Sevin Rosen Funds
North America, Texas, United States, Dallas
Co-Investments: 10
The Aurora Funds
North America, North Carolina, United States, Durham
Co-Investments: 6
ATA Ventures
North America, California, United States, Redwood City
Co-Investments: 6
In-Q-Tel
North America, Virginia, United States, Arlington
Co-Investments: 6
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 5
El Dorado Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
Lux Capital
North America, New York, United States, New York
Co-Investments: 7
VantagePoint Capital Partners
North America, California, United States, San Bruno
Co-Investments: 7
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 17

Which angels does 180 Degree Capital often collaborate with?

AD
North America, Massachusetts, United States, Boston
Shared Deals: 1
DT
North America, Colorado, United States, Denver
Shared Deals: 1

What are some of recent deals done by 180 Degree Capital?

Magnolia NeuroSciences

New York, New York, United States

Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.

BiotechnologyHealth CareNeuroscienceWellness
Series AAug 13, 2018
Amount Raised: $31,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series BJul 12, 2018
Amount Raised: $14,400,000
EchoPixel

Los Altos Hills, California, United States

EchoPixel develops medical imaging devices that enable doctors to use CT images of a patient’s abdomen and display a 3D model.

BiotechnologyHealth CareMedical
Series AOct 19, 2017
Amount Raised: $8,500,000
NGX Bio

South Plainfield, New Jersey, United States

NGX Bio is an online marketplace platform for online DNA sequencing services.

BiotechnologyGeneticsMarketplaceMedicalOnline Portals
Series UnknownAug 15, 2017
Amount Raised: $3,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series UnknownJun 27, 2017
Amount Raised: $20,000,000
Lodo Therapeutics

New York, New York, United States

Lodo Therapeutics is a drug discovery and development company.

BiotechnologyHealth CarePharmaceutical
Series AJan 11, 2016
Amount Raised: $17,000,000
Petra Pharma

New York, New York, United States

Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AJan 6, 2016
Amount Raised: $48,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series ADec 12, 2015
Amount Raised: $12,500,000
AgBiome

Raleigh, North Carolina, United States

AgBiome discovers and develops innovative biological and trait products for crop protection.

AgricultureBiotechnologyService Industry
Series BAug 20, 2015
Amount Raised: $34,500,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series UnknownFeb 5, 2015
Amount Raised: $3,100,000